Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis | 8 | 2024 | 384 | 2.900 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 10 | 1.600 |
Why?
|
| MicroRNAs | 3 | 2023 | 47 | 1.190 |
Why?
|
| Cartilage, Articular | 5 | 2024 | 550 | 1.130 |
Why?
|
| Transcription Factor RelA | 1 | 2024 | 14 | 0.950 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 14 | 0.940 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2023 | 7 | 0.900 |
Why?
|
| Gene Editing | 2 | 2024 | 6 | 0.890 |
Why?
|
| Mice | 9 | 2024 | 1683 | 0.830 |
Why?
|
| Chondrocytes | 6 | 2024 | 208 | 0.750 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2011 | 39 | 0.740 |
Why?
|
| Cell Differentiation | 2 | 2011 | 152 | 0.710 |
Why?
|
| Animals | 12 | 2024 | 4724 | 0.680 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2023 | 36 | 0.660 |
Why?
|
| Nerve Growth Factor | 3 | 2024 | 33 | 0.550 |
Why?
|
| Chondrogenesis | 3 | 2024 | 31 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2011 | 10 | 0.460 |
Why?
|
| Osteoblasts | 2 | 2011 | 63 | 0.440 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 782 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 234 | 0.360 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 36 | 0.360 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2024 | 7 | 0.240 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2024 | 15 | 0.240 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2024 | 6 | 0.240 |
Why?
|
| Cell Proliferation | 2 | 2018 | 204 | 0.230 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2024 | 35 | 0.230 |
Why?
|
| NF-kappa B | 1 | 2024 | 110 | 0.220 |
Why?
|
| Joints | 1 | 2024 | 99 | 0.220 |
Why?
|
| beta Catenin | 1 | 2023 | 50 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 466 | 0.200 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2019 | 32 | 0.200 |
Why?
|
| Inflammation | 1 | 2024 | 362 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2020 | 686 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2011 | 12 | 0.190 |
Why?
|
| Osteogenesis | 2 | 2011 | 107 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 15 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 24 | 0.170 |
Why?
|
| Smad1 Protein | 1 | 2019 | 3 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2020 | 177 | 0.160 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 9 | 0.160 |
Why?
|
| Menisci, Tibial | 2 | 2020 | 187 | 0.160 |
Why?
|
| Mandibular Condyle | 1 | 2018 | 5 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 61 | 0.160 |
Why?
|
| Temporomandibular Joint | 1 | 2018 | 12 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 32 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 124 | 0.150 |
Why?
|
| Mice, Knockout | 4 | 2020 | 323 | 0.150 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2019 | 130 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 261 | 0.130 |
Why?
|
| Humans | 4 | 2024 | 31070 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 14 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 19 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 43 | 0.100 |
Why?
|
| Plasmids | 1 | 2011 | 45 | 0.100 |
Why?
|
| Transfection | 1 | 2011 | 126 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 66 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 5 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 18 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 59 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2010 | 37 | 0.090 |
Why?
|
| Protein Binding | 1 | 2010 | 124 | 0.090 |
Why?
|
| Homeostasis | 2 | 2019 | 86 | 0.080 |
Why?
|
| Disease Progression | 2 | 2020 | 830 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2020 | 6 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 147 | 0.040 |
Why?
|
| Synoviocytes | 1 | 2019 | 4 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 14 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 60 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 81 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 32 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 20 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 43 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2018 | 31 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 165 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2018 | 46 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 586 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 287 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 498 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 379 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 428 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 81 | 0.040 |
Why?
|
| Aggrecans | 1 | 2017 | 157 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 239 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 733 | 0.030 |
Why?
|